Skip to main content
Earnings Labs
Zymeworks Inc. logo

Zymeworks Inc. (ZYME)

NASDAQ·Healthcare·Biotechnology

$30.18

+1.81%

Mkt Cap $2.06B

Analyst Ratings

Buy

13

Hold

0

Sell

0

Price Target (28 analysts)

$41.40

Range $32.00 – $55.00

Implied Upside

+37.2%

Consensus $41.40 vs current $30.18